FDA commissioner warns of risk to agency under RFK Jr. influencenews2024-11-12T19:08:54+00:00November 12th, 2024|Endpoints News|
Merck KGaA plans China submission after late-stage win for tumor drugnews2024-11-12T16:09:12+00:00November 12th, 2024|Endpoints News|
Apollo makes a deal worth up to $926M; Abeona resubmits gene therapynews2024-11-12T16:07:00+00:00November 12th, 2024|Endpoints News|
Exclusive: GV-backed Medicaid startup Diverge Health raises $52Mnews2024-11-12T14:00:37+00:00November 12th, 2024|Endpoints News|
AstraZeneca, Daiichi Sankyo replace lung cancer filing for Enhertu successornews2024-11-12T12:21:18+00:00November 12th, 2024|Endpoints News|
Bayer not eyeing new deals to address Xarelto sales erosionnews2024-11-12T12:21:04+00:00November 12th, 2024|Endpoints News|
AstraZeneca budgets another $2B to boost manufacturing and R&D in USnews2024-11-12T12:08:44+00:00November 12th, 2024|Endpoints News|
Alentis nabs $181M to broaden Claudin’s scope in ADCsnews2024-11-12T12:00:37+00:00November 12th, 2024|Endpoints News|
Roche teams with Flare Therapeutics on transcription factorsnews2024-11-12T12:00:35+00:00November 12th, 2024|Endpoints News|
Trace Neuroscience raises $101M for ALS and other neuro conditionsnews2024-11-12T12:00:33+00:00November 12th, 2024|Endpoints News|
